Project Description

S T A L M A N S Peter
Title: Professor Doctor
Suffix: M.D., Ph.D.
Nationality: Belgian
Address:
Dept. Ophthalmology, UZLeuven.
Herestraat 49
B-3000 Leuven, Belgium
Phone: +32-16-33 26 60, Fax: +32-16-33 23 67
E-mail: Peter.Stalmans@uzleuven.be

Professional career:
-Resident-in training in Ophthalmology at UZ Leuven, supervisors: Prof. L. Missotten and Prof. W. Spileers
• August 1993 – July 1994 full-time
• August 1994 – January 1998 part-time
• February 1998 – April 1999 full-time.
-Research Assistant of the FWO-Vlaanderen, August 1994 – January 1998, Laboratorium voor Fysiologie, KULeuven, promotor: Prof. B. Himpens.
-Junior staff member at the Dept. of Ophthalmology UZLeuven: May 1 – December 31,
1999
-Staff member at the Dept. of Ophthalmology UZLeuven: August 1, 2000 – present
-Associate Professor at the Katholic University of Leuven, Belgium: October 1, 2001 – present

Memberships:
-American Academy of Ophthalmology (AAO)
-European Vision & Eye Research (EVER)
-Belgisch Oftalmologisch Gezelschap (BOG)
-American Society of Retina Specialists (ASRS)
-European Vitreoretinal Society (EVRS)
-Euretina

Foreign trainings:
-Laboratory visit at Massachussetts Eye & Ear Infirmary, Harvard Medical School, Boston, August 1994
-Vitreo-retinal surgery fellowship in the “Oogziekenhuis Rotterdam”: January 1 – July
31, 2000: fulltime, August 1 – December 31, 2000: part-time.

Research grants :
-Research grant from Fonds voor Research in Oftalmologie/Fonds de Recherche en Ophtalmologie (FRO) 1997 for research project “Transplantation of in vitro cultured RPE cells in age-related macular degeneration”, in collaboration with Prof. W. Spileers and Prof. L. Dralands.
-Horlet-Dapsens price Medical Sciences KULeuven 1998 for vitreo-retinal surgery fellowship in the “Oogziekenhuis Rotterdam” in 2000.
-Chair for intra-ocular surgery: research grant received from Bausch & Lomb, 2007-
2009. Extended for two years in 2010.
-Chair for examination of the effect of pharmacological and surgical vitrectomy:
research grant received from Thrombogenics: 2013-2016.